Navigation Links
ICBS to focus on pharmaceutical and environmental markets
Date:8/5/2009

NEW YORK, MONTREAL, and SAN DIEGO, Aug. 5 /PRNewswire-FirstCall/ - ICBS Ltd., (OTCPK: ICBT), board of directors, announced that the company will focus its efforts on the pharmaceutical market through its subsidiary, Canadian Bio Med Systems Ltd., and the environmental market through its partnership with BioSpec Global Solutions Inc., of Quebec.

                       High Interest in a New Approach

"We feel that at this point, we should concentrate on the most promising investments and that is with Canadian Bio Med Systems and BioSpec Global Solutions. We have therefore decided to cease offering business consulting services through our subsidiary, Inter Canadian Business Services along with divesting our interest in Ramapo Valley Brewery" said Dr. George Tsoukas, Chairman.

ICBS has positioned itself with 51% ownership in Canadian Bio Med Systems and 25% interest in BioSpec Global Solutions.

These companies have entered a multi billion dollar market place in recession proof industries.

ICBS will continue to acquire undervalued opportunities in these selective high-growth industries to create value for our shareholders and target partners by combining expertise in both the product and capital markets. Taking interest in companies to align with their long-term interest and help build enduring value for our investors.

Canadian Bio Med Systems, has acquired the licensing rights to two new potentially revolutionary drugs in the billion dollar ophthalmic arena. The drug for the treatment of Glaucoma is being developed by Daniel Stamer, PhD and Ronald Heimark, PhD at the University of Arizona. Glaucoma is a prevalent eye disease is one of the leading causes of blindness in the world, and Age-Related Macular Degeneration (AMD) is the leading cause of blindness, worldwide, for people over 55 years of age. The incidence of AMD in persons aged 55 is 1% and increases to 15% for persons aged 80. This debilitating disease has proven to be difficult to treat and only a very few drugs have been developed which have positive effects.

BioSpec Global Solutions has developed state-of-the-art technologies for rapid, onsite (remote) monitoring of microbial contamination in drinking water, recreational water, agriculture food production, pharmaceuticals and medical applications. TOGS(TM) 9000 instrument is a single test, precision, portable incubator utilizing the patented technology provide on-site testing of microbial contamination in drinking water. Used in conjunction with a chromogenic reagent, it provides an accurate, virtually fool-proof microbial test for field, rural and remote applications in the detection of Total Coliforms and E.coli to WHO standards using globally approved methods (USEPA, AWWA-APHA). The company holds world wide patents

NB. This news release includes statements that constitute forward-looking statements. Please be aware that any such forward-looking statements are not guarantees of future performance and involve significant risks and uncertainties, and that actual results may vary materially from those in the forward-looking statements as a result of any number of factors, including the risk factors contained in the Company's disclosure documents.


'/>"/>
SOURCE INTER CANADIAN BUSINESS SERVICE
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Alzheimers Disease is the Focus of TBSI Annual Neuroscience Symposium
2. Osteotech to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference
3. Arena Pharmaceuticals to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference
4. NuVasive to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference
5. Zimmer Holdings to Present at BMO Capital Markets Ninth Annual Focus on Healthcare Conference
6. AHMC Inc. & AHMC Healthcare Inc. Continue to Focus on Cost-Management
7. Bionovo to Present at the BMO Capital Markets Ninth Annual Focus on Healthcare Conference
8. STAAR Surgical to Present at BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York
9. Nfocus Neuromedical Announces European Approval for Novel Guiding Catheter at Society of NeuroInterventional Surgery
10. Ex- White House Drug Spokesman Urges Double Drug Treatment; Bob Weiner and Policy Analyst Zoe Pagonis Highlight Drug Wars Wrong Focus
11. Pennsylvania Insurance Department Examinations to Focus on Health Insurance Competition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... The Masters of Science in ... leaders with decades of experience who remain current practitioners in the field. With ... there is a renewed demand for versatile, data-driven leadership.The American University’s MS in ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... for Assisted Living (IHCA/INCAL), will serve as a healthcare industry expert at the ... The panel discussion, moderated by Inside Indiana Business host Gerry Dick, will feature ...
(Date:1/23/2017)... ... January 23, 2017 , ... Steviva ... organic certification under the USDA National Organic Program (NOP) for its Portland SQF ... have established organic production and handling systems to complement our current rigorous food-safety ...
(Date:1/23/2017)... , ... January 23, 2017 ... ... Foundation (OREF), in partnership with the American Society of Anesthesiologists® (ASA®), the ... (APSF), the American Academy of Orthopaedic Surgeons (AAOS) and the Cigna Foundation, ...
(Date:1/23/2017)... , ... January 23, 2017 , ... “Crossing the Bar”: ... ten minutes of a woman’s life. “Crossing the Bar” is the creation of published ... three children. , Charlotte, who credits the inspiration of the book to her ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)...  Using Astute Medical,s NephroCheck Test ... kidney injury (AKI) after open-heart surgery and providing ... significantly improved outcomes by reducing the occurrence ... percent, according to a study published ... Medicine. Experience the interactive Multimedia ...
(Date:1/23/2017)... January 23, 2017 Ahead of today,s trading ... how they have fared at the close: Kite Pharma Inc. (NASDAQ: ... OVAS ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... were relative laggards on Friday, January 20 th , 2017, down ... research reports on these stocks now at: ...
(Date:1/23/2017)... New York , January 23, 2017 ... Non-Invasive Prenatal Testing Market was valued at US$0.53 bn in ... expanding at a strong 17.50% CAGR between 2014 and 2022. The ... Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 ... Non-invasive ...
Breaking Medicine Technology: